| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |